TG Therapeutics (TGTX) announced the presentation of data highlighting BRIUMVI in patients with relapsing forms of multiple sclerosis, at the ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the American ...

Sridhar Manyem, senior director, AM Best, will deliver a pair of presentations at the conference ... operating performance, ...

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis ...

VG-3927 showed a predictable and dose-dependent pharmacokinetic (PK) profile that supports once-daily dosing. These data demonstrated that VG-3927 has high CNS penetrance with an estimated cerebral ...

Businesses and non-profit organizations in southwestern Saskatchewan looking to elevate their game are in for an exciting ...

Q2 2025 Earnings Call Transcript April 17, 2025 Forestar Group Inc. misses on earnings expectations. Reported EPS is $0.64 ...

Self-described ‘drag performer’ who uses ‘they/them’ pronouns says sex binary comes from eugenics during University of ...

This high-profile event brought together a diverse assembly of leading scientists, senior naval and defence officials, and ...

Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as ...

An update on the legal tech market’s past week, from product launches to new partnerships. The fast-paced legal tech world is ...